Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Fh, Schagen"'
Publikováno v:
Europe PubMed Central
The current treatment of haemophiliacs consists of injection of concentrates of blood clotting factors VIII (haemophilia A) and IX (haemophilia B). The inconvenience of the multiple injections needed, and the risk of transmission of infectious agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9d6c06001b33f04ce7c99cb52b8c4fdc
https://pubmed.ncbi.nlm.nih.gov/9623157
https://pubmed.ncbi.nlm.nih.gov/9623157
Publikováno v:
Europe PubMed Central
Haemophilia A is a bleeding disorder that affects approximately 1 in 10,000 males. It is caused by a deficiency of functional blood-clotting factor VIII. Protein-replacement therapy has been effective as treatment, resulting in a vast improvement in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1dd13779426cf20843ca72e4c1ea6c76
http://europepmc.org/abstract/med/9607109
http://europepmc.org/abstract/med/9607109
Autor:
Schagen FH; 1 Netherlands Commission on Genetic Modification (COGEM) , 3720 AN Bilthoven, The Netherlands ., Hoeben RC, Hospers GA
Publikováno v:
Human gene therapy [Hum Gene Ther] 2014 Oct; Vol. 25 (10), pp. 893-6.
Autor:
Schagen FH; Department of Medical Oncology, VU University Medical Center, 1181 HV Amsterdam, The Netherlands., Graat HC, Carette JE, Vellinga J, van Geer MA, Hoeben RC, Dermody TS, van Beusechem VW
Publikováno v:
Human gene therapy [Hum Gene Ther] 2008 Aug; Vol. 19 (8), pp. 783-94.
Autor:
Graat HC; Department of Orthopedic Surgery, VU University medical center, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. hca.graat@vumc.nl, van Beusechem VW, Schagen FH, Witlox MA, Kleinerman ES, Helder MN, Gerritsen WR, Kaspers GJ, Wuisman PI
Publikováno v:
Molecular cancer [Mol Cancer] 2008 Jan 23; Vol. 7, pp. 9. Date of Electronic Publication: 2008 Jan 23.
Autor:
Graat HC; Department of Medical Oncology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands., Carette JE, Schagen FH, Vassilev LT, Gerritsen WR, Kaspers GJ, Wuisman PI, van Beusechem VW
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2007 May; Vol. 6 (5), pp. 1552-61.
Autor:
Carette JE; Department of Medical Oncology, Gene Therapy Division, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Graat HC, Schagen FH, Mastenbroek DC, Rots MG, Haisma HJ, Groothuis GM, Schaap GR, Bras J, Kaspers GJ, Wuisman PI, Gerritsen WR, van Beusechem VW
Publikováno v:
Virology [Virology] 2007 Apr 25; Vol. 361 (1), pp. 56-67. Date of Electronic Publication: 2006 Dec 19.
Autor:
Graat HC; Department of Orthopedic Surgery, VU University Medical Center, Amsterdam, The Netherlands. gaetan.des-guetz@wanadoo.fr, Witlox MA, Schagen FH, Kaspers GJ, Helder MN, Bras J, Schaap GR, Gerritsen WR, Wuisman PI, van Beusechem VW
Publikováno v:
British journal of cancer [Br J Cancer] 2006 Jun 19; Vol. 94 (12), pp. 1837-44. Date of Electronic Publication: 2006 May 30.
Autor:
Schagen FH; Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands. e.schagen@vumc.nl, Wensveen FM, Carette JE, Dermody TS, Gerritsen WR, van Beusechem VW
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2006 May; Vol. 13 (5), pp. 997-1005. Date of Electronic Publication: 2006 Mar 03.
Autor:
Lamfers ML; Department of Neurosurgery, Division of Gene Therapy, VU University Medical Center, Amsterdam, The Netherlands. M.Lamfers@vumc.nl, Gianni D, Tung CH, Idema S, Schagen FH, Carette JE, Quax PH, Van Beusechem VW, Vandertop WP, Dirven CM, Chiocca EA, Gerritsen WR
Publikováno v:
Cancer research [Cancer Res] 2005 Oct 15; Vol. 65 (20), pp. 9398-405.